Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for AVITA Medical (RCEL) over the last 6 years, with Q3 2025 value amounting to 46.76%.

  • AVITA Medical's Return on Capital Employed rose 476400.0% to 46.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 46.76%, marking a year-over-year increase of 476400.0%. This contributed to the annual value of 0.46% for FY2023, which is 1900.0% down from last year.
  • Per AVITA Medical's latest filing, its Return on Capital Employed stood at 46.76% for Q3 2025, which was up 476400.0% from 37.6% recorded in Q2 2025.
  • AVITA Medical's 5-year Return on Capital Employed high stood at 46.76% for Q3 2025, and its period low was 37.6% during Q2 2025.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.36% (2021), whereas its average is 0.21%.
  • The largest annual percentage gain for AVITA Medical's Return on Capital Employed in the last 5 years was 476400bps (2025), contrasted with its biggest fall of -369100bps (2025).
  • Over the past 5 years, AVITA Medical's Return on Capital Employed (Quarter) stood at 0.19% in 2021, then crashed by -62bps to 0.31% in 2022, then plummeted by -65bps to 0.51% in 2023, then crashed by -71bps to 0.88% in 2024, then surged by 5442bps to 46.76% in 2025.
  • Its Return on Capital Employed was 46.76% in Q3 2025, compared to 37.6% in Q2 2025 and 0.88% in Q3 2024.